and bed partner's observation of apnoeas. '2 However, none of these are sufficiently specific to be diagnostically useful, the most helpful being the presence ofapnoeas in 75% ofpatients with the sleep apnoea/hypopnoea syndrome but apnoeas were also present in about 60% of patients without it. Thus, symptoms alone cannot usefully predict which patient in a specialist clinic will turn out to have sleep apnoea.
Features on examination found to be suggestive ofthe sleep apnoea/hypopnoea syndrome include being male,'2 obese,'2 and hypertensive,2 and the presence ofa narrowed pharynx with an enlarged uvula.' Even when symptoms and examination were combined, only about 50% of patients with the sleep apnoea/hypopnoea syndrome and 70% of patients without it were correctly identified by an experienced clinician' and thus further investigation is essential.
Monitoring techniques
The sleep apnoea/hypopnoea syndrome was originally diagnosed by polysomnography which involved overnight recording of sleep, breathing patterns, and oxygenation (table) . However, the need for this relatively expensive investigation has been questioned as a result of both the limitation of health care budgets and the flood of patients being referred for investigation. The diagnostic value of the separate components of polysomnography have therefore been examined.
The recording of sleep quality and duration appears to play little part in the clinical diagnosis of classical sleep apnoea/hypopnoea syndrome according to a study of is to use total sleep time as the denominator for the apnoea + hypopnoea frequency. However, 89 of 91 patients found to have >15 apnoeas + hypopnoeas/hour of sleep also had >10 apnoeas + hypopnoeas/hour in bed and only six of the 109 with <15 apnoeas + hypopnoeas/hour when asleep exceeded the 10 apnoeas + hypopnoeas/hour in bed threshold. All of these six had 10-13 apnoeas + hypopnoeas/hour of sleep.3 The expense of recording sleep does not therefore appear to be justified on the grounds of providing the denominator for apnoea + hypopnoea frequency.
The major use ofsleep recording may be in the identification of transient arousals. At present, however, there is no agreement on the definition of arousal,45 and it is probable that cortical electroencephalographic (EEG) changes are not needed to produce the pathophysiological consequences of arousal.6 This is an area of major research activity at present but, from the clinical point of view, it is not a reason for recording sleep quality overnight. Indeed, it may well be that arousals will be better detected by looking at changes in blood pressure6 or respiratory pattern than by EEG.
The neuromuscular variable that should be recorded during a sleep study is limb movement, as periodic limb movement disorder (PLMD) may result in daytime sleepiness. PMLD is found in at least 5% of patients referred to a respiratory sleep clinic3 and patients may benefit from treatment of this condition. The classical way of diagnosing PLMD has been by recording leg electromyography (EMG) oximetry in the sleep apnoea/hypopnoea syndrome, and it must be remembered that oximetry will be less useful in detecting patients with the upper airways resistance syndrome in which there may be recurrent arousal associated with upper airway narrowing but no change in ventilation and little or no saturation (see below).9 Patients whose sleep apnoea/hypopnoea syndrome is not detected by oximetry tend to be younger and better oxygenated. 3 In such individuals long apnoeas are required before any detectable desaturation occurs. It is important to realise that the deterioration in daytime function4 and the apnoea-related increase in blood pressure relates to the frequency of arousals and not to the extent of desaturation. Thus, patients frequently have severe apnoea/hypopnoea syndrome but normal oximetry traces (figure). One third of the patients who had more than 15 apnoeas + hypopnoeas/hour of sleep (median 28, maximum 47/hour) had fewer than five 4% desaturations/hour.3 It is imperative that this limitation of oximetry is realised by all who use this technique in isolation, and that patients who are symptomatic but have normal oximetry values are investigated further.
The sleep apnoea syndrome was initially diagnosed from recurrent episodes of flow cessation. More recently, however, it has been realised that events in which there is continued airflow but reduced thoracoabdominal movement -so called hypopnoeas -are also associated with recurrent arousals and similar clinical sequelae.'°Indeed, even hypoventilation may not be necessary for the clinical features of the syndrome,9 giving rise to the term the upper airways resistance syndrome. There is considerable confusion between centres with some diagnosing hypopnoeas, others partial airways obstruction, and others the upper airways resistance syndrome in similar patients. In some ways this difference is semantic, but it is important that the prevalence of the upper airways resistance syndrome in the absence of hypoventilation is clarified so that a rational plan for diagnosing such 17 and loud intermittent snoring has been seen as one of the pathognomonic features of the sleep apnoea/hypopnoea syndrome. However, the sensitivity of devices based on snoring alone has been poor at around 27% although the specificity has been high. ' 6 Thus, these devices should not be used in isolation to exclude the sleep apnoea/ hypopnoea syndrome.
Limited sleep study equipment A confusing array of limited sleep study devices is available which use varying combinations of the above sensors. It is beyond the scope of this article to compare and contrast their advantages and disadvantages and, indeed, in a rapidly changing market any such review would be outdated by the time it was published. The common factor between most of these systems is that they are relatively poorly validated and potential purchasers need to ensure that they realise the limitations of the system being considered, and carefully examine independent data on the false positives and false negatives produced by the system under consideration. Most such systems contain oximeters but, in some, the validation data suggest that little additional advantage is obtained from the other sensors. ' 
Conclusions
It is difficult and dangerous to draw too many firm conclusions in this area when there are rapid changes occurring both in the definition of the disease and in the technology available. Nevertheless, clinical guidelines must be produced, however imperfect they may soon appear to be.
The first guideline must be that it is imperative that those performing sleep studies of whatever type are fully trained in the techniques employed. They must be aware of the advantages and disadvantages of the approach used, and particularly be alert to the frequency of and reasons for false positive and false negative studies. They must be fully conversant with all other conditions which enter into the differential diagnosis, and know how these should be investigated, even if they themselves are not going to treat these conditions. They must always put the results of studies into the clinical context of the patient's complaints.
Few centres can afford the luxury of performing polysomnography on all patients referred and, indeed, polysomnography is clearly not required for the clinical management of most patients. The approach adopted will depend upon the patient's presenting features and the facilities available. It is useful to divide new patients into at least four categories on the basis of their presenting features, as follows: This scheme supposes access to limited sleep study equipment capable of measuring breathing pattern, snoring, oxygenation and leg movement. Such systems should soon become available in all district general hospitals. It is reasonable for hospitals without them to use oximetryfor patients with ahigh probability ofhaving the sleep apnoea/hypopnoea syndrome. Those who are confirmed on oximetry to have the sleep apnoea/hypopnoea syndrome can then be referred for CPAP therapy rapidly, but all other patients will need to be referred for limited sleep studies or for overnight polysomnography.
Diagnosing the sleep apnoea/hypopnoea syndrome cost effectively remains a major challenge for respiratory medicine. Respiratory physicians have shown that the measurement of many of the neurophysiological variables hitherto regarded as essential for its diagnosis are not necessary. It is imperative that respiratory physicians now clarify which respiratory variables must be recorded and how they should be analysed to produce cheap, preferably domiciliary, sleep recordings with high reliability and high positive and negative predictive values. 
